Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01267981Phase 3Completed
Phase 3, randomised, single-blind trial of polyethylene glycol 3350 + bisacodyl in gastrointestinal bleeding, sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Frequencies of the diagnoses of clinically significant lesions. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01267981.